In breast cancer, the prognostic significance of GRK6 or its role in modulating cancer metastasis remains largely unknown even though GRK2 and GRK4, not GRK3, upregulation have been found to promote tumorigenesis, migration/invasion and metastasis in breast cancer cells [17–19]. Here, GRK2 is linked to breast carcinoma.